UMOVY ACIDO HIALURONICO recalled over undeclared ingredients
- Recall date
- May 21, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Umary-USA.com recalls UMOVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, U…
- Recall number
- D-0493-2025
- FDA classification
- Class I
- Brand / firm
- Umary-USA.com
- Sold / distributed
- U.S. Nationwide via internet.
Why it was recalled
Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
UMOVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7503046054134
Get recall alerts
Free email alert whenever Umary-USA.com has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Umary-USA.com